EnteroTarget ApS: Financial statements 2020
CVR: 39315769
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
EnteroTarget ApS (CVR 39315769) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 60,326 and a net result of DKK 46,880 compared with DKK -15,465 the year before. Equity in the 2020 report amounted to DKK 251,670. The solvency ratio was 69.5%.
- Gross Profit
- DKK 60,326
- Profit/Loss
- DKK 46,880
- Equity
- DKK 251,670
- Total Assets
- DKK 361,896
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 60 t. | 47 t. | 252 t. | - |
| 2019 | - | -20 t. | -15 t. | 205 t. | - |
| 2018 | - | -39 t. | -31 t. | 20 t. | - |
Official annual report
How creditworthy is EnteroTarget ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
EnteroTarget ApS has published its annual report for 2019. Gross profit came to DKK -19,827, and the net result was DKK -15,465.
About EnteroTarget ApS
EnteroTarget ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jørgen Olsen. The board consists of Jesper Thorvald Troelsen (chair), Jørgen Olsen, Mohammad Taha Yassin and Sebastien Olivier Marie Pratt. The company's owners include Stig Henning Møller Nielsen, NEO Anderson Holding ApS and TroePaz Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -743,935 and a net result of DKK -451,011 compared with DKK -257,942 the year before. Equity in the 2025 report amounted to DKK 4,079,894.